Trial intelligence / Profile preview

METRIC: Metformin in Intrahepatic Cholestasis of Pregnancy

NCT03056274Phase 3Unknown

Sponsor
Epsom and St Helier University Hospitals NHS Trust
Start
Jan 2019
Primary completion
Jun 2019
Modality
Small Molecules
01

Overview

A Phase 3 trial of liquid metformin (Aspargo Labs) in intrahepatic cholestasis of pregnancy (ICP), sponsored by Epsom and St Helier University Hospitals NHS Trust. Status: unknown.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

intrahepatic cholestasis of pregnancy (ICP)

Beyond the preview

Go deeper on NCT03056274.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03056274.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call